StockData
enVVeno Medical Corp logo

enVVeno Medical Corp (NVNO) stock

NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.25−0.32 (-5.75%)

Close on Nov 20, 2026Market cap $3.65MP/E –Yield –

enVVeno Medical gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

enVVeno Medical's gross profit for the twelve months ending Mar 31, 2019 was $186.73K. For fiscal 2018 it was $186.55K, up 7508.2% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2018Dec 31, 2018$186.55K+7508.2%
FY2017Dec 31, 2017$2.45K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2019Mar 31, 2019$31.24K-59.5%
Q4 FY2018Dec 31, 2018$30.46K–
Q3 FY2018Sep 30, 2018$41.66K+7.4%
Q2 FY2018Jun 30, 2018$83.36K–
Q4 FY2017Dec 31, 2017$77.14K–
Q3 FY2017Sep 30, 2017-$105.06K–
Q2 FY2017Jun 30, 2017$38.80K–

More enVVeno Medical figures

See a number that looks wrong?